Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alain Monjardet
Observed names:
A Monjardet,
A. Monjardet
Institution:
Debiopharm (Switzerland)
Observed institutions:
Debiopharm (Switzerland),
Galapagos (France)
OpenAlex ID:
A5004066237
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2- a ]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis
2017
·
Nicolas Desroy
, Christopher Housseman
, et al.
·
Journal of Medicinal Chemistry
·
157
Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis
2021
·
Franck Brebion
, Romain Gosmini
, et al.
·
Journal of Medicinal Chemistry
·
72
Discovery, Structure–Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors
2017
·
Agnès Joncour
, Nicolas Desroy
, et al.
·
Journal of Medicinal Chemistry
·
67
Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2019
·
Xiaoyun Tang
, Melinda Wuest
, et al.
·
Molecular Cancer Therapeutics
·
54
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases
2024
·
Christophe Peixoto
, Agnes Joncour
, et al.
·
Journal of Medicinal Chemistry
·
28
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312
2023
·
Taouès Temal-Laib
, Christophe Peixoto
, et al.
·
Journal of Medicinal Chemistry
·
25
PDF
Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment
2015
·
Roland Blanque
, Nicolas Desroy
, et al.
·
European Respiratory Journal
·
7
P072 GLPG0634, the first selective JAK1 inhibitor, shows strong activity in the mouse DSS-colitis model
2014
·
D. Merciris
, C. Delachaume
, et al.
·
Journal of Crohn s and Colitis
·
7
OP0161 The JAK1 selective inhibitor filgotinib regulates both enthesis and colon inflammation in a mouse model of psoriatic arthritis
2017
·
C Robin-Jagerschmidt
, S Lavazais
, et al.
·
Annals of the Rheumatic Diseases
·
5
PDF
Structure–Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 Inhibitor
2025
·
Hans Kelgtermans
, Maxim De Wachter
, et al.
·
Journal of Medicinal Chemistry
·
3
Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS
2026
·
Léo Marx
, Josée Hue-Perron
, et al.
·
Cell Reports Medicine
·
1
Autotaxin Inhibitorsin IPF: Elucidation of a Novel Binding Mode for GLPG1690
2019
·
B. Heckmann
, R. Blanque
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Abstract 1683: Enhancing therapeutic efficacy and overcoming resistance with a novel dual-payload antibody-drug conjugate technology
2026
·
Antoine Attinger
, Léo Marx
, et al.
·
Cancer Research
Abstract 1160: Debio 1562M, a 2ndgeneration ADC targeting CD37, shows high potency against AML and MDS and safe toxicological profile for future clinical development
2025
·
Lisa Ivanschitz
, Josée Hue-Perron
, et al.
·
Cancer Research
Data from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
Figure S1 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Figure S7 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
Figure S2 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
Figure S6 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
Figure S4 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
Figure S3 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Figure S5 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Figure S7 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Figure S6 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Figure S4 from Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer
2023
·
Xiaoyun Tang
, Melinda Wuest
, et al.
PDF
Show more works
View as search
Works count:
32
Citation count:
427
H-index:
7
I10-index:
6
Year
Topic
Type